Action of tyrosinase on alpha and beta-arbutin: A kinetic study

PLoS One. 2017 May 11;12(5):e0177330. doi: 10.1371/journal.pone.0177330. eCollection 2017.

Abstract

The known derivatives from hydroquinone, α and β-arbutin, are used as depigmenting agents. In this work, we demonstrate that the oxy form of tyrosinase (oxytyrosinase) hydroxylates α and β-arbutin in ortho position of the phenolic hydroxyl group, giving rise to a complex formed by met-tyrosinase with the hydroxylated α or β-arbutin. This complex could evolve in two ways: by oxidizing the originated o-diphenol to o-quinone and deoxy-tyrosinase, or by delivering the o-diphenol and met-tyrosinase to the medium, which would produce the self-activation of the system. Note that the quinones generated in both cases are unstable, so the catalysis cannot be studied quantitatively. However, if 3-methyl-2-benzothiazolinone hydrazone hydrochloride hydrate is used, the o-quinone is attacked, so that it becomes an adduct, which can be oxidized by another molecule of o-quinone, generating o-diphenol in the medium. In this way, the system reaches the steady state and originates a chromophore, which, in turn, has a high absorptivity in the visible spectrum. This reaction allowed us to characterize α and β-arbutin kinetically as substrates of tyrosinase for the first time, obtaining a Michaelis constant values of 6.5 ± 0.58 mM and 3 ± 0.19 mM, respectively. The data agree with those from docking studies that showed that the enzyme has a higher affinity for β-arbutin. Moreover, the catalytic constants obtained by the kinetic studies (catalytic constant = 4.43 ± 0.33 s-1 and 3.7 ± 0.29 s-1 for α and β-arbutin respectively) agree with our forecast based on 13 C NMR considerations. This kinetic characterization of α and β-arbutin as substrates of tyrosinase should be taken into account to explain possible adverse effects of these compounds.

MeSH terms

  • Agaricales / enzymology
  • Arbutin / chemistry
  • Arbutin / pharmacology*
  • Benzothiazoles / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Hydrazones / pharmacology
  • Hydrogen Peroxide / pharmacology
  • Kinetics
  • Molecular Docking Simulation
  • Monophenol Monooxygenase / antagonists & inhibitors
  • Monophenol Monooxygenase / metabolism*
  • Oxygen Consumption / drug effects
  • Substrate Specificity / drug effects
  • Time Factors

Substances

  • Benzothiazoles
  • Enzyme Inhibitors
  • Hydrazones
  • Hydrogen Peroxide
  • Arbutin
  • Monophenol Monooxygenase
  • 3-methyl-2-benzothiazolone hydrazone

Grants and funding

This work was supported by the Fundación Seneca (CARM, Murcia, Spain) under Projects 19545/PI/14, 19304/PI/14 and 19240/PI/14; MINECO under Projects SAF2016-77241-R and CTQ2014-56887-P (Co-financing with Fondos FEDER); and University of Murcia, Murcia under Projects UMU15452 and UMU17766. A. Garcia-Jimenez has a FPU fellowship from the University of Murcia.